Revvity Inc
RVTY94.685USD
-0.375-0.39%
Cierre 04/29, 16:00（ET）Cotizaciones retrasadas 15 min
11.42BCap. mercado
42.25P/E TTM
Más Datos de Revvity Inc Compañía
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Información de la empresa
Código de la empresaRVTY
Nombre de la empresaRevvity Inc
Fecha de salida a bolsaJul 06, 1965
Fundada en1947
Director ejecutivoDr. Prahlad R. Singh, Ph.D.
Número de empleados11000
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 06
Dirección77 4Th Avenue
CiudadWALTHAM
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal02451
Teléfono17816636900
Sitio Webhttps://www.revvity.com/
Código de la empresaRVTY
Fecha de salida a bolsaJul 06, 1965
Fundada en1947
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
42.60K
-0.26%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
23.60K
+3.43%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
11.29K
+7.45%
Mrs. Anita Gonzales
Mrs. Anita Gonzales
Vice President, Controller
Vice President, Controller
4.52K
+19.31%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
3.02K
-28.21%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
42.60K
-0.26%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
23.60K
+3.43%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Americas
1.22B
44.39%
United States
1.10B
39.85%
Other Foreign
1.09B
39.72%
Asia
789.33M
28.65%
Europe
742.61M
26.95%
Other
-2.19B
-79.57%
Por negocio
Por región
Sin datos
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
T. Rowe Price Investment Management, Inc.
17.28%
The Vanguard Group, Inc.
11.85%
T. Rowe Price Associates, Inc.
6.21%
Janus Henderson Investors
5.29%
BlackRock Institutional Trust Company, N.A.
5.00%
Other
54.37%
Estadísticas de accionistas
Accionista
Proporción
T. Rowe Price Investment Management, Inc.
17.28%
The Vanguard Group, Inc.
11.85%
T. Rowe Price Associates, Inc.
6.21%
Janus Henderson Investors
5.29%
BlackRock Institutional Trust Company, N.A.
5.00%
Other
54.37%
Tipo
Accionista
Proporción
Investment Advisor
52.38%
Investment Advisor/Hedge Fund
34.65%
Hedge Fund
2.53%
Bank and Trust
1.60%
Pension Fund
1.55%
Research Firm
1.34%
Sovereign Wealth Fund
1.02%
Individual Investor
0.29%
Family Office
0.05%
Other
4.58%
Participación institucional
Hora de actualización: lun., 20 de ene
Hora de actualización: lun., 20 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
1212
114.89M
95.62%
-2.87M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
2023Q1
1406
108.31M
85.69%
-5.19M
2022Q4
1441
108.60M
86.00%
-7.85M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
T. Rowe Price Investment Management, Inc.
20.76M
17.28%
+2.97M
+16.69%
Dec 31, 2024
The Vanguard Group, Inc.
14.24M
11.85%
+157.96K
+1.12%
Dec 31, 2024
T. Rowe Price Associates, Inc.
7.46M
6.21%
+1.15M
+18.27%
Dec 31, 2024
Janus Henderson Investors
6.36M
5.29%
+23.65K
+0.37%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
6.01M
5%
-158.82K
-2.58%
Dec 31, 2024
State Street Global Advisors (US)
5.17M
4.3%
-13.79K
-0.27%
Dec 31, 2024
EdgePoint Investment Group Inc.
4.06M
3.38%
+1.37M
+51.10%
Dec 31, 2024
Mitsubishi UFJ Asset Management Co., Ltd.
3.38M
2.82%
+69.03K
+2.08%
Dec 31, 2024
Capital Research Global Investors
2.99M
2.49%
-97.75K
-3.17%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.90M
2.41%
+37.67K
+1.32%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
Otter Creek Focus Strategy ETF
2.72%
T Rowe Price Capital Appreciation Equity ETF
2.21%
Franklin Genomic Advancements ETF
1.87%
Invesco S&P 500 Equal Weight Health Care ETF
1.52%
Simplify Health Care ETF
1.28%
VanEck Morningstar SMID Moat ETF
1.25%
First Trust Indxx Medical Devices ETF
1.24%
Janus Henderson US Sustainable Equity ETF
1.11%
First Trust Health Care Alphadex Fund
0.87%
ROBO Global Healthcare Technology & Innovation ETF
0.86%
Ver más
Otter Creek Focus Strategy ETF
Proporción2.72%
T Rowe Price Capital Appreciation Equity ETF
Proporción2.21%
Franklin Genomic Advancements ETF
Proporción1.87%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.52%
Simplify Health Care ETF
Proporción1.28%
VanEck Morningstar SMID Moat ETF
Proporción1.25%
First Trust Indxx Medical Devices ETF
Proporción1.24%
Janus Henderson US Sustainable Equity ETF
Proporción1.11%
First Trust Health Care Alphadex Fund
Proporción0.87%
ROBO Global Healthcare Technology & Innovation ETF
Proporción0.86%
Dividendos
Un total de
168.35M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
Apr 25, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 11, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 11, 2023
Jul 20, 2023
Jan 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 12, 2023 going ex on Apr 20, 2023
Apr 21, 2023
May 12, 2023
Apr 20, 2023
Oct 27, 2022
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 10, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Feb 10, 2023
Jan 19, 2023
Jul 22, 2022
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 11, 2022 going ex on Oct 20, 2022
Oct 21, 2022
Nov 11, 2022
Oct 20, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos